# PALLAS (NCT02513394)

> PALbociclib CoLlaborative Adjuvant Study

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02513394
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Alliance Foundation Trials, LLC.
- Conditions: Breast Cancer
- Interventions: Palbociclib; Standard Adjuvant Endocrine Therapy
- Enrollment: 5796
- Primary outcome: Invasive Disease Free Survival (iDFS)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 58
- YouTube: 30
- Podcasts: 18

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=pallas-nct02513394

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02513394", "email": "<work email>"}; the inbox owner confirms by the emailed link.